<DOC>
	<DOCNO>NCT00485459</DOCNO>
	<brief_summary>The purpose protocol investigate acute treatment efficacy , safety , tolerability atomoxetine once-daily dose strategy Taiwanese child adolescent ADHD .</brief_summary>
	<brief_title>Atomoxetine Hydrochloride Versus Placebo Taiwanese Children Adolescents With ADHD</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Subject must ADHD meet DSMIV disease diagnostic criterion well severity criterion Subjects must age 6 16 year Subjects must take medication use treat ADHD must complete washout procedure Subjects must able swallow capsule Subjects must normal intelligence judgment investigator . Normal intelligence define without evidence significant general intellectual deficit expect achieve score 80 formal IQ testing administer . Weigh le 20 kg 60 kg study entry Have history Bipolar I II disorder , psychosis , pervasive developmental disorder Meet DSMIV criterion anxiety disorder assess investigator Have history seizure disorder ( febrile seizure ) prior ECG abnormality relate epilepsy , subject take ( currently take ) anticonvulsant seizure control Subjects history severe allergies 1 class medication multiple adverse drug reaction .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>